Keywords: millennium, 1st-qtr, losses, narrow, usa-based, pharmaceuticals, posted
Millennium's 1st-qtr losses narrow
Article | 09 May 2005
USA-based Millennium Pharmaceuticals has posted a net loss of $36.4 million, or $0.12 per share, for the first quarter of 2005 versus $40.6 million, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
